Acorah Software Products - Accounts Production 16.5.460 false true 31 December 2023 1 January 2023 false true No description of principal activity 1 January 2024 31 December 2024 31 December 2024 09907661 Mr N G Dwyer iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 09907661 2023-12-31 09907661 2024-12-31 09907661 2024-01-01 2024-12-31 09907661 frs-core:CurrentFinancialInstruments 2024-12-31 09907661 frs-bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 09907661 frs-bus:FilletedAccounts 2024-01-01 2024-12-31 09907661 frs-bus:Micro-entities 2024-01-01 2024-12-31 09907661 frs-bus:AuditExempt-NoAccountantsReport 2024-01-01 2024-12-31 09907661 frs-bus:Director1 2024-01-01 2024-12-31 09907661 frs-bus:Director1 2023-12-31 09907661 frs-bus:Director1 2024-12-31 09907661 2022-12-31 09907661 2023-12-31 09907661 2023-01-01 2023-12-31 09907661 frs-core:CurrentFinancialInstruments 2023-12-31
Registered number: 09907661
I.C.E. Medical Solutions Limited
Unaudited Financial Statements
For The Year Ended 31 December 2024
Mountsides Limited
Chartered Accountants
2 Mountside
Stanmore
Middlesex
HA7 2DT
I.C.E. Medical Solutions Limited
Balance Sheet
As At 31 December 2024
Balance Sheet
Registered number: 09907661
2024 2023
£ £
Current assets 7,316 7,328
Creditors: Amounts Falling Due Within One Year (6,503 ) (7,702 )
NET CURRENT ASSETS (LIABILITIES) 813 (374 )
TOTAL ASSETS LESS CURRENT LIABILITIES 813 (374 )
NET ASSETS/(LIABILITIES) 813 (374 )
CAPITAL AND RESERVES 813 (374 )

Notes

1. General Information
I.C.E. Medical Solutions Limited is a private company, limited by shares, incorporated in England & Wales, registered number 09907661 . The registered office is 2 Mountside, Stanmore, Middlesex, HA7 2DT.
The presentation currency of the financial statements is the Pound Sterling (£)
2. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2023: 1)
1 1
3. Directors Advances, Credits and Guarantees
Included within Debtors are the following loans to directors:
As at 1 January 2024 Amounts advanced Amounts repaid Amounts written off As at 31 December 2024
£ £ £ £ £
Mr N G Dwyer - 6,174 - - 6,174
The above loan is unsecured, interest free and repayable on demand.
4. TRANSITION TO FINANCIAL REPORTING STANDARD 105
These are the first financial statements that comply with Financial Reporting Standard 105. The date of transition is 1 January 2023.
The policies applied under the company's previous accounting framework are not materially different from Financial Reporting Standard 105 and have not impacted on equity or profit or loss.
Page 0
Page 1
I.C.E. Medical Solutions Limited
Balance Sheet (continued)
As At 31 December 2024
For the year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Mr N G Dwyer
Director
26 September 2025